Tysabri gets boost from label change, new diagnostic
January 23 2012
Biogen Idec and Elan, which market Tysabri for multiple sclerosis, won approval to add new safety information to the drug's ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.